Adicet Bio, Inc. · NASDAQ:ACET
Orbimed Advisors Israel II LTD sold 104,658 Adicet Bio, Inc. shares (Form 4)
Traded Apr 7 to Apr 8, 2026 · Filed Apr 9, 2026
From Apr 7 to Apr 8, 2026, Orbimed Advisors Israel II LTD (10% owner) sold 104,658 Adicet Bio, Inc. shares at an average US$6.45 for US$675K, leaving 0 shares. Filed Apr 9, 2026 (Form 4).
- Sold
- 104,658 shares
- Price
- US$6.45 average (US$6.29 to US$6.53)
- Value
- US$675K
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Common Stock | Sale | 29,319 | US$6.53 | 34,923 | Indirect |
| Apr 7, 2026 | Common Stock | Sale | 2,400 | US$6.38 | 32,523 | Indirect |
| Apr 8, 2026 | Common Stock | Sale | 32,523 | US$6.29 | 0 | Indirect |
| Apr 8, 2026 | Common Stock | Sale | 40,416 | US$6.52 | 0 | Indirect |
Source
Related
- Adicet Bio, Inc.
- Orbimed Advisors Israel II LTD
- Adicet Bio, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Form 4 · Shah Rajeev M. · Apr 29, 2026
- Form 4 · RA Capital Healthcare Fund LP · Apr 13, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Apr 13, 2026